| 000 | 01090 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250515154337.0 | ||
| 264 | 0 | _c20090413 | |
| 008 | 200904s 0 0 eng d | ||
| 022 | _a1875-6182 | ||
| 024 | 7 |
_a10.2174/187152509787047649 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTharp, D L | |
| 245 | 0 | 0 |
_aThe intermediate-conductance Ca2+ -activated K+ channel (KCa3.1) in vascular disease. _h[electronic resource] |
| 260 |
_bCardiovascular & hematological agents in medicinal chemistry _cJan 2009 |
||
| 300 |
_a1-11 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aEndothelium, Vascular |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPotassium Channels, Calcium-Activated _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProtective Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aVascular Diseases _xdrug therapy |
| 700 | 1 | _aBowles, D K | |
| 773 | 0 |
_tCardiovascular & hematological agents in medicinal chemistry _gvol. 7 _gno. 1 _gp. 1-11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/187152509787047649 _zAvailable from publisher's website |
| 999 |
_c18597081 _d18597081 |
||